03.11.25 -- Oral Solid Dosage Formulation And Process Development: A Case Study

Explore the advantages of Liquid Chromatography-Mass Spectrometry system monitoring software in PFAS analysis, including improvements in resource efficiency and operational performance.

Pre-use, post-sterilization integrity testing (PUPSIT) ensures filters remain undamaged and effective during aseptic manufacturing. Learn how you can successfully perform PUPSIT with proven solutions.

How should you approach building your aseptic processing line? Gain insight into the advantages of using a modular, configurable technology rather than custom fill-finish solutions.

Find out how a non-destructive method can be developed to test container closure integrity in autoinjectors equipped with an optically transparent window.

Multicomponent filling and sterilizing systems represent unique advantages for vaccine production. Discover how B/F/S systems can be adapted for production without incurring any product degradation.

Watch as an expert discusses the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.

A PDA survey reveals moderate digitalization in pharma, highlighting gaps in advanced integration. Read about a system that accelerates digital transformation with scalable solutions for Pharma 4.0.

Modulated DSC addresses challenges in pharmaceutical material characterization that enables precise analysis of glass and overlapping transitions to enhance insights beyond standard DSC.

Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Examine various dosing solutions and learn how to streamline your pediatric development journey.

Uncover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.

See how an integrated drug substance and drug product CMC strategy, along with technical case studies from process and analytical development, provide insight into tailored product-specific solutions.

Ensure downstream clinical success by exploring the benefits of evaluating targeted oncology molecules in healthy volunteers to apply an effective platform to accelerate drug product optimization.

Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.

A biotech with limited experience in the development and manufacture of high potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.